NatSec Biotech

Author

About the author

Last updated

NatSec Biotech is published under the byline of Alexander Titus.

Titus is a congressionally appointed commissioner on the National Security Commission on Emerging Biotechnology, which Congress created in the Fiscal Year 2022 National Defense Authorization Act to review emerging biotechnology's implications for U.S. national security and recommend action. The commission lists him among its commissioners, and its final report, released in April 2025, quotes him by name. That report is a congressional commission's analysis and set of recommendations to Congress, not a national strategy adopted by the government. (Commission roster; final report.)

This publication is independent. It is not a publication of the commission, does not speak for the commission or any of its members, and examines the commission's arguments as it examines any other source: by reading the evidence behind them. Where the writing draws on the commission's report, it attributes the commission's judgments to the commission.

The chapters, analyses, and book manuscript are produced through an automated documentary research and editorial system that works under his byline and direction. The methodology page explains exactly how, including what the system does not do. The disclosures page lists relevant affiliations.

Public profiles: LinkedIn · Bluesky